What you'll learn in this expert session
This course will look at practical steps that can be taken to improve vaccine access and uptake in older people, an update on upcoming changes to the schedule, examine when unfunded vaccines are still clinically important, preview the upcoming new and important zoster vaccine and explain how adult immunisations need to be timed in the midst of COVID.
Learning Objectives:
- Identify the vaccine-preventable diseases that currently pose the greatest risk in the elderly
- Define Immunosenescence and outline its effects
- Outline the features of Herpes Zoster infection
- Discuss new developments in vaccine production that benefit people over the age of 65
-
Apply data from the Shingrix trials to patient education and immunisation practice
About the Expert
Prof Tony Cunningham AO
Professor Cunningham is an infectious diseases physician, clinical virologist and scientist. He is Director, Centre for Virus Research at The Westmead Institute for Medical Research (WIMR); Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2); and Professor in the Faculty of Medicine and Health at the University of Sydney
Course curriculum
-
1
How to complete this course
-
Instructions
-
-
2
Adult Vaccination – Updates and Developments
-
Summary and learning objectives
-
Video presentation (35 mins)
-
Quiz: test your learning (10 mins)
-
-
3
Document your CPD here
-
CPD Documentation and Reflection Activity Tool
-
-
4
Feedback
-
Please let us know your thoughts
-